SPONSOR

Todd C. Lee MD MPH FIDSA

Total Trials

Recruiting

Phases

Phase 3

Conditions studied: Pneumocystis Pneumocystis Pneumonia Pneumocystis Jirovecii Infection Pneumocystis Infections Pneumocystis Carinii Infection Pneumocystosis; Pneumonia (Etiology)Pneumocystis Carinii; Infection, Resulting From HIV Disease Pneumocystosis Associated With AIDS Staphylococcus Aureus Endocarditis Prosthetic Valve Endocarditis

Clinical Trials by Todd C. Lee MD MPH FIDSA

NCT04851015 Phase 3

Recruiting

Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia

Pneumocystis

NCT07253688 Phase 3

Recruiting

Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus

Staphylococcus Aureus Endocarditis

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology